Skip to main
ADUS
ADUS logo

Addus HomeCare (ADUS) Stock Forecast & Price Target

Addus HomeCare (ADUS) Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 22%
Buy 56%
Hold 11%
Sell 11%
Strong Sell 0%

Bulls say

Addus HomeCare Corp has demonstrated robust organic revenue growth, with impressive Year-over-Year (y/y) figures of +12.3% in 2023, +7.7% in 2024, and +7.4% in 2025 year-to-date, indicating a strong recovery and ongoing demand in its Personal Care segment. The recent +2.6% Medicare Hospice rate increase, effective October 1, 2025, further enhances the company's revenue potential within its Hospice segment, which is projected to achieve revenue growth of +5% to +7%. Additionally, strategic opportunities for mergers and acquisitions, along with operational enhancements from leadership changes within the Hospice division, are expected to provide significant near-term upside for the company.

Bears say

Addus HomeCare has experienced same-store declines in 2025 year-to-date results, primarily due to the effects of Medicaid redeterminations, which have led to administrative challenges in onboarding new patients and increased discharges relative to new admissions. Approximately 97% of its segment revenues are vulnerable to uncertainty regarding future Medicaid funding, further complicating the financial outlook as influenced by the One Big Beautiful Bill Act (OBBBA). Although the company maintains a favorable long-term demand backdrop and has executed steadily, its equity performance has lagged behind the broader post-acute care sector, indicating a disconnect between equity valuation and underlying fundamentals.

Addus HomeCare (ADUS) has been analyzed by 9 analysts, with a consensus rating of Buy. 22% of analysts recommend a Strong Buy, 56% recommend Buy, 11% suggest Holding, 11% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Addus HomeCare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Addus HomeCare (ADUS) Forecast

Analysts have given Addus HomeCare (ADUS) a Buy based on their latest research and market trends.

According to 9 analysts, Addus HomeCare (ADUS) has a Buy consensus rating as of Dec 15, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $137.11, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $137.11, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Addus HomeCare (ADUS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.